Skip to main content

Table 1 Characteristics of the all groups

From: Investigating the effect of quadruple therapy with Saccharomyces boulardii or Lactobacillus reuteri strain (DSMZ 17648) supplements on eradication of Helicobacter pylori and treatments adverse effects: a double-blind placebo-controlled randomized clinical trial

 

Group C

Group S

Group P

p value

Age (years)

Mean ± SD

46.57 ± 14.20

49.32 ± 13.42

47.38 ± 14.25

0.58

Sex

Male

34.6% (18)

48.1% (25)

34.6% (18)

0.26

Female

65.4% (34)

51.9% (27)

65.4% (34)

Smoking

Yes

17.3% (9)

32.7% (17)

19.2% (10)

0.12

No

82.7% (43)

67.3% (35)

80.8% (42)

Endoscopic reasons

Dyspepsia

59.6% (31)

67.3% (35)

67.3% (35)

0.63

Heart Burn

25% (13)

25% (13)

21.2% (11)

0.86

Endoscopic pattern of gastritis

Antral gastritis

92.3% (48)

82.7% (43)

90.4% (47)

0.26

Corpus gastritis

23.1% (12)

21.2% (11)

38.5% (20)

0.09

Pan-gastritis

3.8% (2)

11.5% (6)

3.8% (2)

0.22

Duodenal ulcer

3.8% (2)

0.0% (0)

1.9% (1)

0.77

Gastric ulcer

0.0% (0)

1.9% (1)

5.8% (3)

0.32

Esophagitis

0.0% (0)

0.0% (0)

0.0% (0)

–

Normal

1.9% (1)

1.9% (1)

0.0% (0)

1.00